Mercer Global Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
24,882
+13,512
| +119% | +$657K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $387K | Buy |
11,370
+1,390
| +14% | +$47.3K | ﹤0.01% | 1619 |
|
|
2024
Q4 | $393K | Sell |
9,980
-1,598
| -14% | -$62.9K | ﹤0.01% | 1584 |
|
|
2024
Q3 | $528K | Buy |
11,578
+791
| +7% | +$36.1K | ﹤0.01% | 1311 |
|
|
2024
Q2 | $583K | Buy |
10,787
+447
| +4% | +$24.1K | ﹤0.01% | 1223 |
|
|
2024
Q1 | $705K | Sell |
10,340
-696
| -6% | -$47.5K | ﹤0.01% | 1111 |
|
|
2023
Q4 | $691K | Buy |
11,036
+51
| +0.5% | +$3.19K | ﹤0.01% | 1146 |
|
|
2023
Q3 | $499K | Buy |
10,985
+395
| +4% | +$17.9K | ﹤0.01% | 1253 |
|
|
2023
Q2 | $595K | Sell |
10,590
-2,087
| -16% | -$117K | ﹤0.01% | 1153 |
|
|
2023
Q1 | $573K | Buy |
12,677
+307
| +2% | +$13.9K | ﹤0.01% | 1137 |
|
|
2022
Q4 | $503K | Buy |
12,370
+137
| +1% | +$5.57K | ﹤0.01% | 1201 |
|
|
2022
Q3 | $799K | Sell |
12,233
-920
| -7% | -$60.1K | ﹤0.01% | 939 |
|
|
2022
Q2 | $800K | Sell |
13,153
-235
| -2% | -$14.3K | ﹤0.01% | 940 |
|
|
2022
Q1 | $840K | Buy |
13,388
+8,499
| +174% | +$533K | ﹤0.01% | 966 |
|
|
2021
Q4 | $370K | Buy |
4,889
+714
| +17% | +$54K | ﹤0.01% | 1357 |
|
|
2021
Q3 | $467K | Buy |
4,175
+855
| +26% | +$95.6K | ﹤0.01% | 1194 |
|
|
2021
Q2 | $537K | Buy |
3,320
+372
| +13% | +$60.2K | ﹤0.01% | 1110 |
|
|
2021
Q1 | $359K | Buy |
2,948
+383
| +15% | +$46.6K | ﹤0.01% | 1234 |
|
|
2020
Q4 | $393K | Buy |
+2,565
| New | +$393K | ﹤0.01% | 963 |
|